HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹56.55
Day range
₹55.70 - ₹57.80
Year range
₹51.00 - ₹151.45
Market cap
3.08B INR
Avg Volume
60.50K
P/E ratio
13.51
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 732.91M | 20.57% |
Operating expense | 259.43M | 50.44% |
Net income | 53.63M | -60.55% |
Net profit margin | 7.32 | -67.26% |
Earnings per share | — | — |
EBITDA | 39.88M | -70.68% |
Effective tax rate | 11.64% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 608.67M | 116.28% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.16B | — |
Shares outstanding | 55.29M | — |
Price to book | 1.43 | — |
Return on assets | — | — |
Return on capital | 3.54% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 53.63M | -60.55% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600
